vs
Side-by-side financial comparison of AGIOS PHARMACEUTICALS, INC. (AGIO) and Maison Solutions Inc. (MSS). Click either name above to swap in a different company.
Maison Solutions Inc. is the larger business by last-quarter revenue ($27.6M vs $20.0M, roughly 1.4× AGIOS PHARMACEUTICALS, INC.). Maison Solutions Inc. runs the higher net margin — -18.0% vs -541.1%, a 523.1% gap on every dollar of revenue. On growth, AGIOS PHARMACEUTICALS, INC. posted the faster year-over-year revenue change (86.1% vs -10.9%). Over the past eight quarters, AGIOS PHARMACEUTICALS, INC.'s revenue compounded faster (56.1% CAGR vs 42.5%).
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013.
Maison Solutions Inc.MSSEarnings & Financial Report
Maison Solutions Inc. is a specialty home goods retail company that provides a diverse portfolio of stylish, affordably priced furniture, home decor items, and daily household products. Its primary market is the Guangdong-Hong Kong-Macao Greater Bay Area in China, serving mass consumers through both offline physical stores and online e-commerce channels.
AGIO vs MSS — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $20.0M | $27.6M |
| Net Profit | $-108.0M | $-5.0M |
| Gross Margin | 90.6% | 23.4% |
| Operating Margin | -608.9% | -4.9% |
| Net Margin | -541.1% | -18.0% |
| Revenue YoY | 86.1% | -10.9% |
| Net Profit YoY | -11.9% | -1840.5% |
| EPS (diluted) | $-1.86 | $-0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $20.0M | $27.6M | ||
| Q3 25 | $12.9M | $27.2M | ||
| Q2 25 | $12.5M | $34.4M | ||
| Q1 25 | $8.7M | $32.3M | ||
| Q4 24 | $10.7M | $29.4M | ||
| Q3 24 | $9.0M | $28.2M | ||
| Q2 24 | $8.6M | $16.9M | ||
| Q1 24 | $8.2M | $13.6M |
| Q4 25 | $-108.0M | $-5.0M | ||
| Q3 25 | $-103.4M | $-1.5M | ||
| Q2 25 | $-112.0M | $-287.4K | ||
| Q1 25 | $-89.3M | $1.0M | ||
| Q4 24 | $-96.5M | $-256.0K | ||
| Q3 24 | $947.9M | $700.9K | ||
| Q2 24 | $-96.1M | $-2.8M | ||
| Q1 24 | $-81.5M | $-549.0K |
| Q4 25 | 90.6% | 23.4% | ||
| Q3 25 | 87.0% | 24.1% | ||
| Q2 25 | 86.3% | 9.5% | ||
| Q1 25 | 87.6% | 21.8% | ||
| Q4 24 | 88.3% | 26.9% | ||
| Q3 24 | 91.3% | 28.9% | ||
| Q2 24 | 82.6% | 13.0% | ||
| Q1 24 | 92.3% | 23.4% |
| Q4 25 | -608.9% | -4.9% | ||
| Q3 25 | -907.4% | 0.7% | ||
| Q2 25 | -1020.1% | -15.9% | ||
| Q1 25 | -1222.0% | 3.7% | ||
| Q4 24 | -1165.3% | 3.2% | ||
| Q3 24 | -1146.9% | 7.3% | ||
| Q2 24 | -1228.3% | -14.4% | ||
| Q1 24 | -1124.3% | -2.3% |
| Q4 25 | -541.1% | -18.0% | ||
| Q3 25 | -803.1% | -5.7% | ||
| Q2 25 | -899.4% | -0.8% | ||
| Q1 25 | -1023.3% | 3.1% | ||
| Q4 24 | -899.6% | -0.9% | ||
| Q3 24 | 10574.7% | 2.5% | ||
| Q2 24 | -1115.7% | -16.4% | ||
| Q1 24 | -995.8% | -4.0% |
| Q4 25 | $-1.86 | $-0.23 | ||
| Q3 25 | $-1.78 | $-0.08 | ||
| Q2 25 | $-1.93 | $-0.02 | ||
| Q1 25 | $-1.55 | $0.06 | ||
| Q4 24 | $-1.44 | $-0.01 | ||
| Q3 24 | $16.22 | $0.04 | ||
| Q2 24 | $-1.69 | $-0.16 | ||
| Q1 24 | $-1.45 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $89.1M | — |
| Total DebtLower is stronger | — | $2.6M |
| Stockholders' EquityBook value | $1.2B | $11.6M |
| Total Assets | $1.3B | $75.4M |
| Debt / EquityLower = less leverage | — | 0.22× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $89.1M | — | ||
| Q3 25 | $92.7M | $1.1M | ||
| Q2 25 | $80.9M | $775.4K | ||
| Q1 25 | $79.0M | $445.4K | ||
| Q4 24 | $76.2M | $355.7K | ||
| Q3 24 | $253.7M | $588.9K | ||
| Q2 24 | $84.5M | $2.1M | ||
| Q1 24 | $118.8M | $9.4M |
| Q4 25 | — | $2.6M | ||
| Q3 25 | — | $2.6M | ||
| Q2 25 | — | $2.6M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $2.5M | ||
| Q2 24 | — | $2.6M | ||
| Q1 24 | — | $2.6M |
| Q4 25 | $1.2B | $11.6M | ||
| Q3 25 | $1.3B | $10.1M | ||
| Q2 25 | $1.4B | $11.7M | ||
| Q1 25 | $1.5B | $12.0M | ||
| Q4 24 | $1.5B | $10.9M | ||
| Q3 24 | $1.6B | $11.2M | ||
| Q2 24 | $660.5M | $10.5M | ||
| Q1 24 | $743.9M | $13.3M |
| Q4 25 | $1.3B | $75.4M | ||
| Q3 25 | $1.4B | $73.3M | ||
| Q2 25 | $1.5B | $77.4M | ||
| Q1 25 | $1.6B | $82.7M | ||
| Q4 24 | $1.7B | $82.7M | ||
| Q3 24 | $1.8B | $82.1M | ||
| Q2 24 | $773.1M | $82.4M | ||
| Q1 24 | $849.7M | $44.2M |
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.24× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-96.2M | $-1.7M |
| Free Cash FlowOCF − Capex | $-97.3M | — |
| FCF MarginFCF / Revenue | -487.5% | — |
| Capex IntensityCapex / Revenue | 5.6% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-377.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-96.2M | $-1.7M | ||
| Q3 25 | $-88.2M | $1.1M | ||
| Q2 25 | $-77.1M | $-1.6M | ||
| Q1 25 | $-111.5M | $1.7M | ||
| Q4 24 | $-133.2M | $1.1M | ||
| Q3 24 | $-84.2M | $3.6M | ||
| Q2 24 | $-72.6M | $-2.6M | ||
| Q1 24 | $-99.9M | $-1.4M |
| Q4 25 | $-97.3M | — | ||
| Q3 25 | $-89.7M | — | ||
| Q2 25 | $-78.0M | — | ||
| Q1 25 | $-112.3M | — | ||
| Q4 24 | $-134.1M | — | ||
| Q3 24 | $-84.6M | — | ||
| Q2 24 | $-72.7M | — | ||
| Q1 24 | $-100.0M | — |
| Q4 25 | -487.5% | — | ||
| Q3 25 | -696.5% | — | ||
| Q2 25 | -626.2% | — | ||
| Q1 25 | -1286.4% | — | ||
| Q4 24 | -1250.1% | — | ||
| Q3 24 | -944.2% | — | ||
| Q2 24 | -844.4% | — | ||
| Q1 24 | -1221.2% | — |
| Q4 25 | 5.6% | — | ||
| Q3 25 | 12.1% | — | ||
| Q2 25 | 7.0% | — | ||
| Q1 25 | 8.8% | — | ||
| Q4 24 | 9.0% | — | ||
| Q3 24 | 4.7% | — | ||
| Q2 24 | 1.8% | — | ||
| Q1 24 | 1.7% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.66× | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.09× | 5.12× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AGIO
Segment breakdown not available.
MSS
| Perishables | $14.4M | 52% |
| Nonperishables | $13.2M | 48% |
